Compared to other forms of acute myeloid leukemia, CBF‐AML has a relatively good prognosis: about 75% of individuals with CBF‐AML achieved a CR following treatment, compared with 43.2% of those with other forms of AML‐M5 children in this study. The gene discussed is CEBPZ; the disease is acute myeloid leukemia.